RE:RE:RE:RE:RE:RE:Sedar entry at 845 amOk skys1 let's look at PE ( the share price to earnings ratio), I see you use an estimate of 300,000,000 shares to an estimated 3 billion offer to buyout the company equals $10.00. So in an established listed senior stock they have roughly a PE ratio of 20 to 25 lets use both to see what that actual individual share price would be, take $10.00 ÷ 20 = $0.50 profit a share or $10.00 ÷ 25 = $0.40 profit a share. Perhaps you know how PE works but some don't and what it means is if TLT'S yearly net profit was $0.40 and it was a slow earning senior company it could be awarded a PE multiple of 25 for that 40 cents which comes out to $10.00.
In a previous post I projected a theoretical profit! If Theralase were in its first year for only profits on NMIBC. So first year TLT might get 10% of the estimated 96,000 bladder patients from only Canada & US (ignoring the possible profit from the rest of the world) so 9,600 is 10% X 50,000 a patient or 100,000 or 150,000? Let's use 50K that comes to $480,000,000 now let's say cost to the company to earn that amount was $280,000,000 so net profit is 200 million ( all fictitious numbers ) so 200 million divided by total shares of 300 million is $0.67 profit for each share with even a low PE ratio of 20 we get $13.40. I would think if they do well they will be awarded a speculative PE ratio of 50 ( $33.50 ) or 75 ( $50.25 ).
My argument against a 3 billion buyout is the hugh profit capability of this company and in my biased opinion $10.00 is a slap in the face.
skys1 wrote
While they could file another Shelf, I have been posting for about 6 months now, there will not be a need for another PP financing. Now that they have these relativly new relationships with two very interested, very well-heeled entities, when the need arises, I believe the cash from either or will be available. That's if TLT still exists as its own separate entity. While many on this board believe current management would discourage an offer from a bidder, if a member of the Big Pharma community wants it and current management won't negotiate, they will accumulate 9.5 % silently, then come with a hostile offer to the true owners, the shareholders. I can assure you if an offer is made in the area I suggested of maybe $3 billion which would be roughly $10 a share, at least 80% of shareholders would gab it and current management's opinion wouldn't mean much - just sayin.